JP2022519045A5 - - Google Patents

Info

Publication number
JP2022519045A5
JP2022519045A5 JP2021544183A JP2021544183A JP2022519045A5 JP 2022519045 A5 JP2022519045 A5 JP 2022519045A5 JP 2021544183 A JP2021544183 A JP 2021544183A JP 2021544183 A JP2021544183 A JP 2021544183A JP 2022519045 A5 JP2022519045 A5 JP 2022519045A5
Authority
JP
Japan
Application number
JP2021544183A
Other languages
Japanese (ja)
Other versions
JP2022519045A (ja
JP7573536B2 (ja
JPWO2020160414A5 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/016120 external-priority patent/WO2020160414A1/en
Publication of JP2022519045A publication Critical patent/JP2022519045A/ja
Publication of JP2022519045A5 publication Critical patent/JP2022519045A5/ja
Publication of JPWO2020160414A5 publication Critical patent/JPWO2020160414A5/ja
Priority to JP2024104756A priority Critical patent/JP2024125391A/ja
Application granted granted Critical
Publication of JP7573536B2 publication Critical patent/JP7573536B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021544183A 2019-01-31 2020-01-31 無細胞dnaを単離するための組成物および方法 Active JP7573536B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024104756A JP2024125391A (ja) 2019-01-31 2024-06-28 無細胞dnaを単離するための組成物および方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962799637P 2019-01-31 2019-01-31
US62/799,637 2019-01-31
PCT/US2020/016120 WO2020160414A1 (en) 2019-01-31 2020-01-31 Compositions and methods for isolating cell-free dna

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024104756A Division JP2024125391A (ja) 2019-01-31 2024-06-28 無細胞dnaを単離するための組成物および方法

Publications (4)

Publication Number Publication Date
JP2022519045A JP2022519045A (ja) 2022-03-18
JP2022519045A5 true JP2022519045A5 (https=) 2023-02-08
JPWO2020160414A5 JPWO2020160414A5 (https=) 2023-02-08
JP7573536B2 JP7573536B2 (ja) 2024-10-25

Family

ID=69740753

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021544183A Active JP7573536B2 (ja) 2019-01-31 2020-01-31 無細胞dnaを単離するための組成物および方法
JP2024104756A Pending JP2024125391A (ja) 2019-01-31 2024-06-28 無細胞dnaを単離するための組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024104756A Pending JP2024125391A (ja) 2019-01-31 2024-06-28 無細胞dnaを単離するための組成物および方法

Country Status (8)

Country Link
US (2) US11643693B2 (https=)
EP (2) EP4567131A3 (https=)
JP (2) JP7573536B2 (https=)
CN (1) CN113661249B (https=)
AU (2) AU2020216438A1 (https=)
CA (1) CA3126428A1 (https=)
ES (1) ES3013495T3 (https=)
WO (1) WO2020160414A1 (https=)

Families Citing this family (85)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4567131A3 (en) * 2019-01-31 2025-09-03 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
WO2020243722A1 (en) 2019-05-31 2020-12-03 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
EP4035161A1 (en) * 2019-09-23 2022-08-03 Grail, LLC Systems and methods for diagnosing a disease condition using on-target and off-target sequencing data
US11891653B2 (en) 2019-09-30 2024-02-06 Guardant Health, Inc. Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
WO2021231921A1 (en) 2020-05-14 2021-11-18 Guardant Health, Inc. Homologous recombination repair deficiency detection
ES3018032T3 (en) 2020-07-30 2025-05-14 Guardant Health Inc Methods for isolating cell-free dna
JP2023540221A (ja) * 2020-08-25 2023-09-22 ガーダント ヘルス, インコーポレイテッド バリアントの起源を予測するための方法およびシステム
CN116438454A (zh) 2020-09-21 2023-07-14 普罗根尼蒂公司 用于分离细胞游离dna的组合物和方法
US20220154285A1 (en) 2020-09-30 2022-05-19 Guardant Health, Inc. Analysis of methylated dna comprising methylation-sensitive or methylation-dependent restrictions
US12234518B2 (en) 2020-10-23 2025-02-25 Guardant Health, Inc. Compositions and methods for analyzing DNA using partitioning and base conversion
EP4251765A1 (en) 2020-11-30 2023-10-04 Guardant Health, Inc. Compositions and methods for enriching methylated polynucleotides
EP4267757A1 (en) * 2020-12-23 2023-11-01 Guardant Health, Inc. Methods and systems for analyzing methylated polynucleotides
WO2022147420A1 (en) * 2020-12-30 2022-07-07 Guardant Health, Inc. Detection of epigenetic status using sequence-specific degradation
WO2022174109A1 (en) 2021-02-12 2022-08-18 Guardant Health, Inc. Methods and compositions for detecting nucleic acid variants
EP4314329A1 (en) * 2021-03-25 2024-02-07 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
JP2024515558A (ja) * 2021-04-08 2024-04-10 デルフィ ダイアグノスティックス インコーポレイテッド ゲノム全体のcfDNA断片化プロファイルを使用するがんを検出する方法
WO2022251655A1 (en) 2021-05-28 2022-12-01 Guardant Health, Inc. Compositions and methods for assaying circulating molecules
JP2024523401A (ja) 2021-06-21 2024-06-28 ガーダント ヘルス, インコーポレイテッド コピー数情報に基づく組織起源分析のための方法および組成物
AU2022318379A1 (en) * 2021-07-27 2024-02-08 Ludwig Institute For Cancer Research Ltd Compositions and methods related to tet-assisted pyridine borane sequencing for cell-free dna
EP4409024A1 (en) * 2021-09-30 2024-08-07 Guardant Health, Inc. Compositions and methods for synthesis and use of probes targeting nucleic acid rearrangements
JP2024540168A (ja) 2021-11-02 2024-10-31 ガーダント ヘルス, インコーポレイテッド 品質管理方法
EP4453241A1 (en) 2021-12-21 2024-10-30 Guardant Health, Inc. Methods and systems for combinatorial chromatin-ip sequencing
EP4453240A1 (en) 2021-12-23 2024-10-30 Guardant Health, Inc. Compositions and methods for detection of metastasis
WO2023130101A2 (en) * 2021-12-30 2023-07-06 AiOnco, Inc. Methods and probes for separating genomic nucleic acid fractions for cancer risk analysis
CA3246524A1 (en) 2022-04-07 2023-10-12 Guardant Health, Inc. TUMOR PRESENCE DETECTION BASED ON THE METHYLATION STATE OF ACELLULAR NUCLEIC ACID MOLECULES
JP2025522763A (ja) 2022-06-30 2025-07-17 ガーダント ヘルス, インコーポレイテッド 異常にメチル化されたdnaの富化
US20240191290A1 (en) 2022-07-21 2024-06-13 Guardant Health, Inc. Methods for detection and reduction of sample preparation-induced methylation artifacts
WO2024059840A1 (en) 2022-09-16 2024-03-21 Guardant Health, Inc. Compositions and methods for analyzing soluble proteins
WO2024073508A2 (en) 2022-09-27 2024-04-04 Guardant Health, Inc. Methods and compositions for quantifying immune cell dna
EP4638781A2 (en) 2022-12-22 2025-10-29 Guardant Health, Inc. Methods involving methylation preserving amplification with error correction
JP2025542261A (ja) 2022-12-22 2025-12-25 ガーダント ヘルス, インコーポレイテッド 統合された対象および全ゲノム体細胞およびdnaメチル化シーケンシングワークフロー
IT202200027141A1 (it) * 2022-12-29 2024-06-29 Andrea Crisanti Metodo per rilevare varianti genetiche minoritarie.
EP4649489A1 (en) 2023-01-11 2025-11-19 Guardant Health, Inc. Joint modeling of longitudinal and time-to-event data to predict patient survival
EP4655416A1 (en) 2023-01-25 2025-12-03 Guardant Health, Inc. Nucleic acid methylation profiling method
CN120898247A (zh) 2023-04-07 2025-11-04 夸登特健康公司 基于无细胞核酸分子的甲基化状态检测肿瘤的存在
US20250101522A1 (en) 2023-04-12 2025-03-27 Guardant Health, Inc. Brca1 promoter methylation in sporadic breast cancer patients detected by liquid biopsy
EP4705514A1 (en) 2023-05-01 2026-03-11 Guardant Health, Inc. Quality control method for enzymatic conversion procedures
WO2024229433A1 (en) 2023-05-03 2024-11-07 Guardant Health, Inc. Methods for analysis of dna methylation
EP4705522A1 (en) 2023-05-05 2026-03-11 Guardant Health, Inc. Cell-free dna blood-based test for cancer screening
WO2024264065A1 (en) 2023-06-23 2024-12-26 Guardant Health, Inc. Methods and compositions for quantifying immune cell nucleic acids
WO2025007034A1 (en) 2023-06-29 2025-01-02 Guardant Health, Inc. Methods for determining surveillance and therapy for diseases
CN121532528A (zh) 2023-06-30 2026-02-13 夸登特健康公司 用于癌症早期检测的方法
CN121532829A (zh) 2023-07-14 2026-02-13 夸登特健康公司 使用来自液体活检的dna甲基化对乳腺肿瘤进行分类
WO2025019297A1 (en) 2023-07-14 2025-01-23 Guardant Health, Inc. Classification of colorectal tumors using dna methylation from liquid biopsy
WO2025024497A1 (en) 2023-07-24 2025-01-30 Guardant Health, Inc. Significance modeling of clonal-level target variants using methylation detection
WO2025029475A1 (en) 2023-07-28 2025-02-06 Guardant Health, Inc. Methods to enrich nucleotide variants by negative selection
CN121844385A (zh) 2023-07-28 2026-04-10 夸登特健康公司 用于鉴定变异来源的方法和系统
WO2025029751A1 (en) 2023-07-31 2025-02-06 Guardant Health, Inc. Methods and systems for identifying tumor origin
WO2025038399A1 (en) 2023-08-11 2025-02-20 Guardant Health, Inc. Methylated enrichment methods for single-molecule genetic and epigenetic sequencing
US20250084469A1 (en) 2023-09-12 2025-03-13 Guardant Health, Inc. Methods for analyzing nucleic acids using sequence read family size distribution
WO2025064706A1 (en) 2023-09-19 2025-03-27 Guardant Health, Inc. Detecting the presence of a tumor based on methylation status of cell-free nucleic acid molecules
WO2025064489A1 (en) 2023-09-20 2025-03-27 Guardant Health, Inc. Systems and methods for real world evidence database data integration
WO2025076452A1 (en) 2023-10-06 2025-04-10 Guardant Health, Inc. Detecting tumor-related information based on methylation status of cell-free nucleic acid molecules
WO2025076425A1 (en) 2023-10-06 2025-04-10 Guardant Health, Inc. Genomic and methylation biomarkers for prediction of copy number loss / gene deletion
WO2025085784A1 (en) 2023-10-18 2025-04-24 Guardant Health, Inc. Genomic and methylation biomarkers for determining patient risk of heart disease and novel genomic and epigenomic drug targets to decrease risk of heart disease and/or improve patient outcome after myocardial infarction or cardiac injury
WO2025090954A1 (en) 2023-10-26 2025-05-01 Guardant Health, Inc. Methods for detecting nucleic acid variants
WO2025090956A1 (en) 2023-10-26 2025-05-01 Guardant Health, Inc. Methods for detecting nucleic acid variants using capture probes
US20250243550A1 (en) 2023-11-15 2025-07-31 Guardant Health, Inc. Minimum residual disease (mrd) detection in early stage cancer using urine
WO2025106263A1 (en) 2023-11-15 2025-05-22 Guardant Health, Inc. Joint modeling of longitudinal and time-to-event data to predict patient survival
WO2025106837A1 (en) 2023-11-15 2025-05-22 Guardant Health, Inc. Tumor fraction and outcome association in a real-world non-small cell lung cancer (nsclc) cohort using a methylation-based circulating tumor dna (ctdna) assay
WO2025106796A1 (en) 2023-11-15 2025-05-22 Guardant Health, Inc. Non-small cell lung cancer (nsclc) histology classification using dna methylation data captured from liquid biopsies
WO2025137620A1 (en) 2023-12-21 2025-06-26 Guardant Health, Inc. Methods for high quality and high accuracy methylation sequencing
WO2025137389A2 (en) 2023-12-22 2025-06-26 Guardant Health, Inc. Methods for targeted single-molecule genetic and epigenetic sequencing
WO2025160433A1 (en) 2024-01-24 2025-07-31 Guardant Health, Inc. Methods for analyzing sequencing reads
WO2025207817A1 (en) 2024-03-26 2025-10-02 Guardant Health, Inc. Method of determining the likelihood of a disease by combining biomarkers and imaging
WO2025207924A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for selective deamination using cpg-binding proteins
WO2025208044A1 (en) 2024-03-28 2025-10-02 Guardant Health, Inc. Methods for cancer detection using molecular patterns
WO2025235602A1 (en) 2024-05-07 2025-11-13 Guardant Health, Inc. Predictive, prognostic signatures for immuno-oncology using liquid biopsy
WO2025235889A1 (en) 2024-05-10 2025-11-13 Guardant Health, Inc. Methods involving multiplexed pooled pcr
WO2025245433A1 (en) * 2024-05-23 2025-11-27 Guardant Health, Inc. Generalized probabilistic generative modeling method for analysis of tumor methylated molecules in target capture regions
WO2025250544A1 (en) 2024-05-31 2025-12-04 Guardant Health, Inc. Methods for analyzing chromatin architecture in tissue to boost detection of cancer associated signals in cell-free dna
WO2026015607A1 (en) 2024-07-09 2026-01-15 Guardant Health, Inc. Methods for partitioning hyper-, hypo-, and non-methylated dna
WO2026015794A1 (en) 2024-07-12 2026-01-15 Guardant Health, Inc. Methods for modifying dna using cpg-specific deamination and uracil base excision
WO2026024692A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Direct methylation single-base resolution sequencing of enriched unmethylated dna
WO2026024817A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Methods and compositions for anchored multiplex ngs workflows
WO2026024956A1 (en) 2024-07-24 2026-01-29 Guardant Health, Inc. Selecting low technical noise biomarkers for sensitive molecular diagnostics
WO2026043718A1 (en) 2024-08-21 2026-02-26 Guardant Health, Inc. Methods to monitor patients treated with a cancer vaccine
WO2026043702A1 (en) 2024-08-21 2026-02-26 Guardant Health, Inc. Methods and approaches for personalized identification and monitoring of extrachromosomal circular dna
WO2026050179A1 (en) 2024-08-26 2026-03-05 Guardant Health, Inc. Tumor fraction (tf) is associated with real-world progression-free survival (rwpfs) in non-small-cell lung cancer (nsclc) patients treated with platinum-based chemotherapy (chemo)
WO2026050287A1 (en) 2024-08-27 2026-03-05 Guardant Health, Inc. Methylation biomarkers for osimertinib treatment management
WO2026060266A1 (en) 2024-09-13 2026-03-19 Guardant Health, Inc. Use of copy number variants for the identification of false positive tumor calls
WO2026064529A2 (en) 2024-09-18 2026-03-26 Guardant Health, Inc. Methods for detecting nucleic acid variants using primers and ligation substrates
WO2026073140A1 (en) 2024-09-27 2026-04-02 Guardant Health, Inc. Framework to identify genomic regions indicative of one or more biological conditions
WO2026076332A1 (en) 2024-10-03 2026-04-09 Guardant Health, Inc. Methods involving multi-modal tumor variant identification and tracking of tumor molecules
WO2026080838A2 (en) 2024-10-11 2026-04-16 Guardant Health, Inc. Methods for detecting nucleic acid variants

Family Cites Families (130)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6582908B2 (en) 1990-12-06 2003-06-24 Affymetrix, Inc. Oligonucleotides
CH686982A5 (fr) 1993-12-16 1996-08-15 Maurice Stroun Méthode pour le diagnostic de cancers.
US20030017081A1 (en) 1994-02-10 2003-01-23 Affymetrix, Inc. Method and apparatus for imaging a sample on a device
JP3102800B2 (ja) 1994-08-19 2000-10-23 パーキン−エルマー コーポレイション 増幅及び連結反応の共役法
US5648245A (en) 1995-05-09 1997-07-15 Carnegie Institution Of Washington Method for constructing an oligonucleotide concatamer library by rolling circle replication
AU2324997A (en) 1996-03-15 1997-10-01 Penn State Research Foundation, The Detection of extracellular tumor-associated nucleic acid in blood plasma or ser um using nucleic acid amplification assays
ATE471150T1 (de) 1996-03-26 2010-07-15 Kopreski Michael S Methoden aus plasma oder serum extrahierte extrazelluraere rna zur diagnoseüberwachung oder evaluation von krebs verwenden
GB9620209D0 (en) 1996-09-27 1996-11-13 Cemu Bioteknik Ab Method of sequencing DNA
GB9626815D0 (en) 1996-12-23 1997-02-12 Cemu Bioteknik Ab Method of sequencing DNA
US6969488B2 (en) 1998-05-22 2005-11-29 Solexa, Inc. System and apparatus for sequential processing of analytes
AR021833A1 (es) 1998-09-30 2002-08-07 Applied Research Systems Metodos de amplificacion y secuenciacion de acido nucleico
EP1165839A2 (en) 1999-03-26 2002-01-02 Whitehead Institute For Biomedical Research Universal arrays
CA2366778C (en) 1999-04-09 2008-07-22 Exact Sciences Corporation Methods for detecting nucleic acids indicative of cancer
CA2304260C (en) 1999-04-20 2009-03-24 Japan Bioindustry Association Method for determining a concentration of target nucleic acid molecules, nucleic acid probes for the method and method for analyzing data obtained by the method
US7501245B2 (en) 1999-06-28 2009-03-10 Helicos Biosciences Corp. Methods and apparatuses for analyzing polynucleotide sequences
US6818395B1 (en) 1999-06-28 2004-11-16 California Institute Of Technology Methods and apparatus for analyzing polynucleotide sequences
US6440706B1 (en) 1999-08-02 2002-08-27 Johns Hopkins University Digital amplification
US6849403B1 (en) 1999-09-08 2005-02-01 Exact Sciences Corporation Apparatus and method for drug screening
US6586177B1 (en) 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
WO2001023610A2 (en) 1999-09-29 2001-04-05 Solexa Ltd. Polynucleotide sequencing
WO2001042781A2 (en) 1999-12-07 2001-06-14 Exact Sciences Corporation Supracolonic aerodigestive neoplasm detection
US20020072058A1 (en) 2000-03-24 2002-06-13 Voelker Leroy L. Method for amplifying quinolone-resistance-determining-regions and identifying polymorphic variants thereof
EP1158055A1 (fr) 2000-05-26 2001-11-28 Xu Qi University of Teaxs Laboratoire de Leucémie Chen Méthode pour le diagnostic de cancers
WO2002004680A2 (en) 2000-07-07 2002-01-17 Visigen Biotechnologies, Inc. Real-time sequence determination
DE60131903T2 (de) 2000-10-24 2008-11-27 The Board of Trustees of the Leland S. Stanford Junior University, Palo Alto Direkte multiplex charakterisierung von genomischer dna
DE10112515B4 (de) 2001-03-09 2004-02-12 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierungsmustern mit hoher Sensitivität
AU2002359522A1 (en) 2001-11-28 2003-06-10 Applera Corporation Compositions and methods of selective nucleic acid isolation
EP1342794B1 (en) 2002-03-05 2005-12-14 Epigenomics AG Method and device for determination of tissue specificity of free floating DNA in bodily fluids
US7727720B2 (en) 2002-05-08 2010-06-01 Ravgen, Inc. Methods for detection of genetic disorders
US7635564B2 (en) 2002-10-25 2009-12-22 Agilent Technologies, Inc. Biopolymeric arrays having replicate elements
US10229244B2 (en) 2002-11-11 2019-03-12 Affymetrix, Inc. Methods for identifying DNA copy number changes using hidden markov model based estimations
CA2519860C (en) 2003-03-21 2018-01-16 Santaris Pharma A/S Short interfering rna (sirna) analogues
EP1641809B2 (en) 2003-07-05 2018-10-03 The Johns Hopkins University Method and compositions for detection and enumeration of genetic variations
DE60328193D1 (de) 2003-10-16 2009-08-13 Sequenom Inc Nicht invasiver Nachweis fötaler genetischer Merkmale
DE10348407A1 (de) 2003-10-17 2005-05-19 Widschwendter, Martin, Prof. Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben
US7169560B2 (en) 2003-11-12 2007-01-30 Helicos Biosciences Corporation Short cycle methods for sequencing polynucleotides
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
US7937225B2 (en) 2004-09-03 2011-05-03 New York University Systems, methods and software arrangements for detection of genome copy number variation
US7170050B2 (en) 2004-09-17 2007-01-30 Pacific Biosciences Of California, Inc. Apparatus and methods for optical analysis of molecules
US20060073506A1 (en) 2004-09-17 2006-04-06 Affymetrix, Inc. Methods for identifying biological samples
US7315019B2 (en) 2004-09-17 2008-01-01 Pacific Biosciences Of California, Inc. Arrays of optical confinements and uses thereof
WO2006047787A2 (en) 2004-10-27 2006-05-04 Exact Sciences Corporation Method for monitoring disease progression or recurrence
US7424371B2 (en) 2004-12-21 2008-09-09 Helicos Biosciences Corporation Nucleic acid analysis
US7482120B2 (en) 2005-01-28 2009-01-27 Helicos Biosciences Corporation Methods and compositions for improving fidelity in a nucleic acid synthesis reaction
US7393665B2 (en) 2005-02-10 2008-07-01 Population Genetics Technologies Ltd Methods and compositions for tagging and identifying polynucleotides
ITRM20050068A1 (it) 2005-02-17 2006-08-18 Istituto Naz Per Le Malattie I Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine.
EP1712639B1 (en) 2005-04-06 2008-08-27 Maurice Stroun Method for the diagnosis of cancer by detecting circulating DNA and RNA
US7666593B2 (en) 2005-08-26 2010-02-23 Helicos Biosciences Corporation Single molecule sequencing of captured nucleic acids
US20090170713A1 (en) 2005-09-29 2009-07-02 Keygene N.V. High throughput screening of mutagenized populations
WO2007087312A2 (en) 2006-01-23 2007-08-02 Population Genetics Technologies Ltd. Molecular counting
US7282337B1 (en) 2006-04-14 2007-10-16 Helicos Biosciences Corporation Methods for increasing accuracy of nucleic acid sequencing
US8383338B2 (en) 2006-04-24 2013-02-26 Roche Nimblegen, Inc. Methods and systems for uniform enrichment of genomic regions
CN103424541B (zh) 2006-05-18 2018-01-30 分子压型学会股份有限公司 确定针对病状的个性化医疗介入的系统和方法
US20080090239A1 (en) 2006-06-14 2008-04-17 Daniel Shoemaker Rare cell analysis using sample splitting and dna tags
US8603749B2 (en) 2006-11-15 2013-12-10 Biospherex, LLC Multitag sequencing ecogenomics analysis-US
US20080131887A1 (en) 2006-11-30 2008-06-05 Stephan Dietrich A Genetic Analysis Systems and Methods
WO2008148072A2 (en) 2007-05-24 2008-12-04 The Brigham And Women's Hospital, Inc. Disease-associated genetic variations and methods for obtaining and using same
EP2164985A4 (en) 2007-06-01 2014-05-14 454 Life Sciences Corp SYSTEM AND METHOD FOR IDENTIFYING INDIVIDUAL SAMPLES FROM A MULTIPLEX MIXTURE
LT2557517T (lt) 2007-07-23 2023-01-10 The Chinese University Of Hong Kong Nukleino rūgščių sekos disbalanso nustatymas
US8338838B2 (en) 2007-12-28 2012-12-25 3M Innovative Properties Company Down-converted light source with uniform wavelength emission
WO2009099602A1 (en) 2008-02-04 2009-08-13 Massachusetts Institute Of Technology Selection of nucleic acids by solution hybridization to oligonucleotide baits
WO2009102632A2 (en) 2008-02-12 2009-08-20 Biocept, Inc. Method for isolating cell free apoptotic or fetal nucleic acids
MX2010010600A (es) 2008-03-28 2011-03-30 Pacific Biosciences California Inc Composiciones y metodos para secuenciacion de acidos nucleicos.
US20090318305A1 (en) 2008-06-18 2009-12-24 Xi Erick Lin Methods for selectively capturing and amplifying exons or targeted genomic regions from biological samples
WO2010021936A1 (en) 2008-08-16 2010-02-25 The Board Of Trustees Of The Leland Stanford Junior University Digital pcr calibration for high throughput sequencing
US8383345B2 (en) 2008-09-12 2013-02-26 University Of Washington Sequence tag directed subassembly of short sequencing reads into long sequencing reads
US20100323348A1 (en) 2009-01-31 2010-12-23 The Regents Of The University Of Colorado, A Body Corporate Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process
WO2011063210A2 (en) 2009-11-20 2011-05-26 Life Technologies Corporation Methods of mapping genomic methylation patterns
US8835358B2 (en) 2009-12-15 2014-09-16 Cellular Research, Inc. Digital counting of individual molecules by stochastic attachment of diverse labels
ES2534758T3 (es) 2010-01-19 2015-04-28 Verinata Health, Inc. Métodos de secuenciación en diagnósticos prenatales
CA2786564A1 (en) 2010-01-19 2011-07-28 Verinata Health, Inc. Identification of polymorphic sequences in mixtures of genomic dna by whole genome sequencing
WO2012006291A2 (en) 2010-07-06 2012-01-12 Life Technologies Corporation Systems and methods to detect copy number variation
EP2599545B1 (en) 2010-07-29 2019-09-04 Toto Ltd. Photocatalyst coated body and photocatalyst coating liquid
CA2811185C (en) 2010-09-21 2020-09-22 Population Genetics Technologies Ltd. Increasing confidence of allele calls with molecular counting
US8725422B2 (en) 2010-10-13 2014-05-13 Complete Genomics, Inc. Methods for estimating genome-wide copy number variations
CA3080686C (en) 2010-10-22 2023-10-10 Cold Spring Harbor Laboratory Varietal counting of nucleic acids for obtaining genomic copy number information
KR20190002733A (ko) 2010-12-30 2019-01-08 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화
US9260753B2 (en) 2011-03-24 2016-02-16 President And Fellows Of Harvard College Single cell nucleic acid detection and analysis
ES2625288T3 (es) 2011-04-15 2017-07-19 The Johns Hopkins University Sistema de secuenciación segura
US9347059B2 (en) 2011-04-25 2016-05-24 Bio-Rad Laboratories, Inc. Methods and compositions for nucleic acid analysis
SG10201605049QA (en) 2011-05-20 2016-07-28 Fluidigm Corp Nucleic acid encoding reactions
KR101454886B1 (ko) 2011-08-01 2014-11-03 주식회사 셀레믹스 핵산분자의 제조방법
CA2852098C (en) 2011-10-21 2023-05-02 Chronix Biomedical Colorectal cancer associated circulating nucleic acid biomarkers
WO2013060762A1 (en) 2011-10-25 2013-05-02 Roche Diagnostics Gmbh Method for diagnosing a disease based on plasma-dna distribution
WO2013138644A2 (en) 2012-03-15 2013-09-19 New England Biolabs, Inc. Methods and compositions for discrimination between cytosine and modifications thereof, and for methylome analysis
GB2533006B (en) 2012-09-04 2017-06-07 Guardant Health Inc Systems and methods to detect copy number variation
US20140066317A1 (en) 2012-09-04 2014-03-06 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20160040229A1 (en) 2013-08-16 2016-02-11 Guardant Health, Inc. Systems and methods to detect rare mutations and copy number variation
US20140287408A1 (en) 2013-03-13 2014-09-25 Abbott Molecular Inc. Target sequence enrichment
GB2528205B (en) 2013-03-15 2020-06-03 Guardant Health Inc Systems and methods to detect rare mutations and copy number variation
CN113337604A (zh) 2013-03-15 2021-09-03 莱兰斯坦福初级大学评议会 循环核酸肿瘤标志物的鉴别和用途
EP4321628B1 (en) 2013-05-23 2025-09-03 The Board of Trustees of the Leland Stanford Junior University Transposition into native chromatin for personal epigenomics
ES2660989T3 (es) 2013-12-28 2018-03-27 Guardant Health, Inc. Métodos y sistemas para detectar variantes genéticas
EP3805404A1 (en) 2014-05-13 2021-04-14 Board of Regents, The University of Texas System Gene mutations and copy number alterations of egfr, kras and met
CN107002122B (zh) 2014-07-25 2023-09-19 华盛顿大学 确定导致无细胞dna的产生的组织和/或细胞类型的方法以及使用其鉴定疾病或紊乱的方法
HRP20220045T1 (hr) 2014-07-25 2022-04-15 Bgi Genomics Co., Limited Postupak za određivanje frakcije slobodnih fetalnih nukleinskih kiselina u uzorku periferne krvi trudnice i njihova uporaba
US20160053301A1 (en) 2014-08-22 2016-02-25 Clearfork Bioscience, Inc. Methods for quantitative genetic analysis of cell free dna
EP3191628B1 (en) 2014-09-12 2022-05-25 The Board of Trustees of the Leland Stanford Junior University Identification and use of circulating nucleic acids
WO2016109452A1 (en) 2014-12-31 2016-07-07 Guardant Health , Inc. Detection and treatment of disease exhibiting disease cell heterogeneity and systems and methods for communicating test results
EP3256605B1 (en) 2015-02-10 2022-02-09 The Chinese University Of Hong Kong Detecting mutations for cancer screening and fetal analysis
US20160281166A1 (en) 2015-03-23 2016-09-29 Parabase Genomics, Inc. Methods and systems for screening diseases in subjects
ES2969767T3 (es) 2015-05-01 2024-05-22 Guardant Health Inc Métodos de diagnóstico
EP3325667B1 (en) 2015-07-21 2020-11-11 Guardant Health, Inc. Locked nucleic acids for capturing fusion genes
IL305462A (en) 2015-07-23 2023-10-01 Univ Hong Kong Chinese DNA fragmentation pattern analysis suitable clean
US12540351B2 (en) 2015-09-02 2026-02-03 Guardant Health, Inc. Identification of somatic mutations versus germline variants for cell-free DNA variant calling applications
US11302416B2 (en) 2015-09-02 2022-04-12 Guardant Health Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications
JP6991134B2 (ja) 2015-10-09 2022-01-12 ガーダント ヘルス, インコーポレイテッド 無細胞dnaを使用する集団ベースの処置レコメンダ
EP3693459A1 (en) 2015-10-10 2020-08-12 Guardant Health, Inc. Methods and applications of gene fusion detection in cell-free dna analysis
WO2017106768A1 (en) 2015-12-17 2017-06-22 Guardant Health, Inc. Methods to determine tumor gene copy number by analysis of cell-free dna
CN109072309B (zh) 2016-02-02 2023-05-16 夸登特健康公司 癌症进化检测和诊断
MX2018010362A (es) * 2016-02-29 2019-03-28 Found Medicine Inc Metodos y sistemas para evaluar carga mutacional de tumores.
MX391039B (es) 2016-04-07 2025-03-21 Univ Leland Stanford Junior Diagnostico no invasivo por medio de la secuenciacion del adn libre de celulas 5-hidroxi-metilado.
EP4488686A3 (en) * 2016-04-14 2025-04-30 Guardant Health, Inc. Methods for early detection of cancer
US11384382B2 (en) * 2016-04-14 2022-07-12 Guardant Health, Inc. Methods of attaching adapters to sample nucleic acids
CN109415763A (zh) * 2016-05-03 2019-03-01 大学健康网络 捕获无细胞的甲基化dna的方法及其用途
EP4257701A3 (en) * 2016-06-30 2023-12-20 Grail, LLC Differential tagging of rna for preparation of a cell-free dna/rna sequencing library
KR102610098B1 (ko) 2016-07-06 2023-12-04 가던트 헬쓰, 인크. 무세포 핵산의 프래그멘톰 프로파일링을 위한 방법
CN116445593A (zh) 2016-08-10 2023-07-18 格里尔公司 测定一生物样品的一甲基化图谱的方法
US9850523B1 (en) 2016-09-30 2017-12-26 Guardant Health, Inc. Methods for multi-resolution analysis of cell-free nucleic acids
JP6560465B1 (ja) 2016-09-30 2019-08-21 ガーダント ヘルス, インコーポレイテッド 無細胞核酸の多重解像度分析のための方法
CA3046007A1 (en) * 2016-12-22 2018-06-28 Guardant Health, Inc. Methods and systems for analyzing nucleic acid molecules
US11993811B2 (en) * 2017-01-31 2024-05-28 Myriad Women's Health, Inc. Systems and methods for identifying and quantifying gene copy number variations
JP2020527340A (ja) 2017-06-30 2020-09-10 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア セルフリーdna中のdnaメチル化を評価するための方法およびシステム
JP7136899B2 (ja) 2018-01-08 2022-09-13 ルドウイグ インスティテュート フォー キャンサー リサーチ エルティーディー シトシン修飾の、亜硫酸水素塩非含有、塩基分解能特定
SG11202011696TA (en) 2018-06-11 2020-12-30 Foundation Medicine Inc Compositions and methods for evaluating genomic alterations
JP7466519B2 (ja) 2018-07-23 2024-04-12 ガーダント ヘルス, インコーポレイテッド 腫瘍遺伝子変異量を腫瘍割合およびカバレッジによって調整するための方法およびシステム
EP4567131A3 (en) * 2019-01-31 2025-09-03 Guardant Health, Inc. Compositions and methods for isolating cell-free dna
WO2020243722A1 (en) * 2019-05-31 2020-12-03 Guardant Health, Inc. Methods and systems for improving patient monitoring after surgery
US11891653B2 (en) * 2019-09-30 2024-02-06 Guardant Health, Inc. Compositions and methods for analyzing cell-free DNA in methylation partitioning assays
CA3157560A1 (en) * 2019-11-26 2021-06-03 Dustin Howard HITE Methods, compositions and systems for improving the binding of methylated polynucleotides

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
JP2022519045A5 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2023551292A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR102021007058A2 (https=)
BR102020022030A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)